News Caristo wins FDA authorization for cardiovascular risk predictorHealthradar5. August 2026 Dive Brief: Caristo Diagnostics has received de novo authorization for an AI tool that quantifies coronary inflammation from routine imaging…
News Caristo Diagnostics Receives FDA De Novo Authorization for CaRi-Heart AI PlatformHealthradar30. Juli 2026 What You Should Know Oxford spin-out Caristo Diagnostics has secured FDA De Novo authorization for CaRi-Heart®, making it the first…
Health Biograph and Caristo Partner to Study Novel AI-Based Cardiac Marker in US PatientsHealthradar2. Oktober 2025 What You Should Know: – Biograph, a preventive health and diagnostics clinic, has announced a partnership with Caristo Diagnostics to…